Our Strategy
Innovative Biosimilars for Rare Diseases, Health and Sustainable Impact.
At NOVUSPHARM, our strategy is built upon a firm and unwavering belief: every Algerian patient deserves fair and equitable access to high-quality biological treatments — including for the rarest conditions.
Our dedication to biosimilars in rare diseases reflects a clear commitment: reducing therapeutic inequalities, fostering local medical excellence, and contributing to Algeria’s healthcare sovereignty.
Strengthening Healthcare Through Innovation and Commitment
We believe progress in healthcare comes from a clear vision and decisive action. By prioritizing innovation, technology transfer, and patient access, we are laying the foundations for a stronger, more independent pharmaceutical industry in Algeria.
Our mission goes beyond delivering therapies — it’s about creating lasting value for patients, the healthcare system, and society. From supporting authorities and medical professionals to driving economic impact, we are dedicated to shaping an ethical, resilient, and forward-looking medical future.
Bringing innovation where it is most needed
We select next-generation biosimilars that meet the highest international standards of quality, safety, and efficacy — with the goal of expanding treatment options for patients living with rare diseases.
Investing in technology transfer
We are fully engaged in transferring know-how, enabling local manufacturing, and building industrial capabilities to lay the foundations for national pharmaceutical independence.
Creating a positive impact on public health and the national economy
By offering reliable, accessible, and cost-effective therapeutic alternatives, we help ease the financial burden on the healthcare system while ensuring optimal patient care.
Being a trusted partner to the Algerian healthcare system
We aspire to become a key player in the Algerian health ecosystem, working hand in hand with authorities, healthcare professionals, and researchers to build an ethical, forward-thinking, and resilient medical future.
Our vision
NOVUSPHARM stands for an Algerian pharmaceutical industry rooted in innovation, scientific excellence, and healthcare sovereignty.
We are a human-scale company with a national ambition: to restore hope to patients, reduce the strain on the healthcare economy, and play an active role in the country’s industrial renewal.
